ASSEMBLY BIOSCIENCES, INC. financial data

Symbol
ASMB on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 269% % -6.3%
Debt-to-equity 106% % -58%
Return On Equity -59% % 51%
Return On Assets -29% % 17%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15,817,140 shares 149%
Common Stock, Shares, Outstanding 15,816,987 shares 149%
Entity Public Float $69,000,000 USD 15%
Common Stock, Value, Issued $16,000 USD 167%
Weighted Average Number of Shares Outstanding, Basic 12,686,122 shares 100%
Weighted Average Number of Shares Outstanding, Diluted 12,686,122 shares 100%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $61,843,000 USD 17%
General and Administrative Expense $18,797,000 USD -15%
Operating Income (Loss) $43,449,000 USD 6.4%
Nonoperating Income (Expense) $4,826,000 USD -21%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $9,196,000 USD 4.3%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $38,547,000 USD 5.5%
Earnings Per Share, Basic -4 USD/shares 31%
Earnings Per Share, Diluted -4 USD/shares 31%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $22,534,000 USD -21%
Cash, Cash Equivalents, and Short-term Investments $232,600,000 USD
Accounts Receivable, after Allowance for Credit Loss, Current $912,000 USD
Assets, Current $236,812,000 USD 141%
Property, Plant and Equipment, Net $229,000 USD -28%
Operating Lease, Right-of-Use Asset $2,644,000 USD 86%
Other Assets, Noncurrent $312,000 USD 0%
Assets $239,997,000 USD 139%
Accounts Payable, Current $1,683,000 USD 26%
Employee-related Liabilities, Current $5,053,000 USD 23%
Accrued Liabilities, Current $5,728,000 USD 20%
Contract with Customer, Liability, Current $42,363,000 USD 30%
Liabilities, Current $53,380,000 USD 28%
Contract with Customer, Liability, Noncurrent $1,715,000 USD -95%
Operating Lease, Liability, Noncurrent $2,207,000 USD 1853%
Liabilities $57,302,000 USD -23%
Accumulated Other Comprehensive Income (Loss), Net of Tax $90,000 USD 42%
Retained Earnings (Accumulated Deficit) $854,137,000 USD -4.7%
Stockholders' Equity Attributable to Parent $182,695,000 USD 603%
Liabilities and Equity $239,997,000 USD 139%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $23,439,000 USD -28%
Net Cash Provided by (Used in) Financing Activities $1,922,000 USD
Net Cash Provided by (Used in) Investing Activities $6,586,000 USD -62%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 15,816,987 shares 149%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $14,931,000 USD -1267%
Deferred Tax Assets, Valuation Allowance $211,614,000 USD 4.5%
Deferred Tax Assets, Gross $212,420,000 USD 4.6%
Operating Lease, Liability $3,089,000 USD 32%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $38,481,000 USD 5.4%
Lessee, Operating Lease, Liability, to be Paid $3,925,000 USD 52%
Operating Lease, Liability, Current $548,000 USD -59%
Lessee, Operating Lease, Liability, to be Paid, Year Two $806,000 USD -31%
Lessee, Operating Lease, Liability, to be Paid, Year One $751,000 USD -46%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $836,000 USD 260%
Lessee, Operating Lease, Liability, to be Paid, Year Three $834,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $131,994,000 USD -11%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $5,175,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Four $863,000 USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $33,000 USD 3.1%
Deferred Tax Assets, Net of Valuation Allowance $806,000 USD 25%
Share-based Payment Arrangement, Expense $3,967,000 USD 19%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%